TY - JOUR
T1 - A bibliometric analysis of scientific production on second-generation anti-psychotic drugs in Malaysia
AU - López-Muñoz, Francisco
AU - Povedano-Montero, Francisco J.
AU - Chee, Kok Yoon
AU - Shen, Winston W.
AU - Fernández-Martín, Poveda
AU - García-Pacios, Javier
AU - Rubio, Gabriel
AU - Álamo, Cecilio
N1 - Publisher Copyright:
© Penerbit Universiti Sains Malaysia, 2018.
PY - 2018/6
Y1 - 2018/6
N2 - Objective: We carried out a bibliometric study on the scientific papers related to second-generation antipsychotic drugs (SGAs) in Malaysia. Methods: With the SCOPUS database, we selected those documents made in Malaysia whose title included descriptors related to SGAs. We applied bibliometric indicators of production and dispersion, as Price’s law and Bradford’s law, respectively. We also calculated the participation index of the different countries. The bibliometric data were also been correlated with some social and health data from Malaysia (total per capita expenditure on health and gross domestic expenditure on R&D). Results: We found 105 original documents published between 2004 and 2016. Our results fulfilled Price’s law, with scientific production on SGAs showing exponential growth (r = 0.401, vs. r = 0.260 after linear adjustment). The drugs most studied are olanzapine (9 documents), clozapine (7), and risperidone (7). Division into Bradford zones yields a nucleus occupied by the Medical Journal of Malaysia, Singapore Medical Journal, Australian and New Zealand Journal of Psychiatry, and Pharmacogenomics. Totally, 63 different journals were used, but only one in the top four journals had an impact factor being greater than 3. Conclusion: The publications on SGAs in Malaysia have undergone exponential growth, without evidence a saturation point.
AB - Objective: We carried out a bibliometric study on the scientific papers related to second-generation antipsychotic drugs (SGAs) in Malaysia. Methods: With the SCOPUS database, we selected those documents made in Malaysia whose title included descriptors related to SGAs. We applied bibliometric indicators of production and dispersion, as Price’s law and Bradford’s law, respectively. We also calculated the participation index of the different countries. The bibliometric data were also been correlated with some social and health data from Malaysia (total per capita expenditure on health and gross domestic expenditure on R&D). Results: We found 105 original documents published between 2004 and 2016. Our results fulfilled Price’s law, with scientific production on SGAs showing exponential growth (r = 0.401, vs. r = 0.260 after linear adjustment). The drugs most studied are olanzapine (9 documents), clozapine (7), and risperidone (7). Division into Bradford zones yields a nucleus occupied by the Medical Journal of Malaysia, Singapore Medical Journal, Australian and New Zealand Journal of Psychiatry, and Pharmacogenomics. Totally, 63 different journals were used, but only one in the top four journals had an impact factor being greater than 3. Conclusion: The publications on SGAs in Malaysia have undergone exponential growth, without evidence a saturation point.
KW - Atypical anti-psychotics
KW - Bibliometrics
KW - Bipolar disorder
KW - Malaysia
KW - Schizophrenia
KW - Second-generation anti-psychotics
UR - http://www.scopus.com/inward/record.url?scp=85049173919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049173919&partnerID=8YFLogxK
U2 - 10.21315/mjms2018.25.3.5
DO - 10.21315/mjms2018.25.3.5
M3 - Article
AN - SCOPUS:85049173919
SN - 1394-195X
VL - 25
SP - 40
EP - 55
JO - Malaysian Journal of Medical Sciences
JF - Malaysian Journal of Medical Sciences
IS - 3
ER -